CNBC's Jim Cramer parsed Wednesday's session, expressing concern about the sectors that led the market's gains. "This was a ...

CNBC's Jim Cramer on Wednesday parsed earnings results from JPMorgan Chase, Wells Fargo, Bank of America, Citigroup, which ...

Kimberly-Clark Corporation (NASDAQ:KMB) is one of the stocks Jim Cramer recently looked at. During the episode, a caller ...

Arm Holdings plc (NASDAQ:ARM) is one of the stocks Jim Cramer recently looked at. A caller mentioned that they have held the ...

Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) is one of the stocks on Jim Cramer’s radar recently. During the lightning round, ...

Jim Cramer recommended holding Texas Instruments (TXN) on CNBC's Mad Money, supported by an analyst's hold rating and raised ...

Okay, the stock’s been troubled, and a lot of that I think is because people are confused about the Chinese, with the ...

Alphabet hits record $338 as Cramer sees 20% upside to $400. AI partnership with Apple and Gemini momentum fuel bullish ...

CNBC's Jim Cramer warns that speculative AI and tech stocks are due for a reckoning, then reveals which companies he's saying to "buy buy buy" instead.

Eli Lilly partnership a "monumental effort" to speed up drug creation, despite Wall Street ignoring major AI shift.

Jim Cramer continues issuing investment advice, this time revealing ‘the stock he most wanted to own’ coming into 2026.

Dynavax Technologies Corporation (NASDAQ:DVAX) is one of the stocks Jim Cramer recently looked at. When a caller noted that ...